Optimizing Clinical Study Report Development Through Lean Authoring: A Framework for Meeting Regulatory Expectations and Preparing for Automation

This review article provides a comprehensive overview of lean authoring in the pharmaceutical industry based on the experience of medical writing leaders, emphasizing its importance for efficiently creating clinical study reports (CSRs) and other clinical documents. Lean authoring is defined as an approach focused on delivering unambiguous, clear, concise, and objective content that meets regulatory reviewer expectations. This will better ensure accessibility, eliminating unnecessary details, and tailoring content to meet the following needs of regulatory reviewers during what is essentially a non-linear review process: a) fast navigation to decision-critical information, b) a clear, logical trail from study design to analyses to results, c) low cognitive burden, and d) fewer review questions resulting from ambiguous language and inconsistency. The benefits of lean authoring include improved readability and reusability of content, enhanced efficiency and cost-effectiveness in document preparation, and more efficient regulatory reviews. These benefits have been observed across many industries. And yet, challenges in implementing lean authoring methods, including resistance to change, are common. To help companies counter resistance to change, this article outlines the benefits of lean authoring and a step-by-step approach to adopting lean authoring methods, understanding regulatory reviewers’ needs, and developing a robust change management plan. Healthcare agency regulatory reviewers have stated their preference for clear and concise information. Our goal is to influence the pharmaceutical industry to adopt lean authoring to achieve this. By optimizing the authoring process, we aim to increase the efficiency of the process, improve the quality of CSRs, and reduce the burden of regulatory reviews.